University of Arizona researchers have revealed new insights into one of the most common complications faced by Parkinson's disease patients: uncontrollable movements that develop after years of ...
Earlier this week, Neurocrine Biosciences reported new real-world clinician survey data showing that INGREZZA (valbenazine) improved uncontrolled movements and day-to-day functioning in adults with ...
In 2024, several research and pharmacological advancements were made for tardive dyskinesia, a movement disorder caused by dopamine-blocking medications. Below are some of the highlights of the year.
Differentiating tardive dyskinesia from other movement disorders can be challenging. "One major criterion is the history of exposure to neuroleptic medications," said Jeff Bronstein, MD, PhD, of the ...
Why INGREZZA data matters for Neurocrine Biosciences stock Neurocrine Biosciences (NBIX) has drawn fresh attention after presenting new real world clinician survey data on INGREZZA in mild tardive ...
Learn about dyskinesia, including its causes, symptoms, types, and available treatment options to help manage involuntary ...
Tardive dyskinesia (TD) is a side effect of antipsychotic or neuroleptic medications that causes involuntary movements of the face, neck, arms, and legs. These movements can affect social life, ...
Tardive dyskinesia stigma can negatively impact your life, but experts say there are a number of ways to lessen its effects.
Tardive dyskinesia is a condition that can cause involuntary movements of the face, including the jaw, lips, and tongue. Although its less common, other parts of the body can also be affected, leading ...
Dyskinesia refers to uncontrolled, involuntary muscle movements ranging from shakes, tics and tremors to full-body movements. It can happen with various neurological conditions. Another type of ...
Tardive dyskinesia is a hyperkinetic movement disorder that causes faces to move involuntarily and abnormally. It is considered to be a drug-induced movement disorder. Movements often occur in the ...